Kenvue Stock - Weekly review and consumer health sector check

Kenvue, the consumer health company carved out of Johnson & Johnson, ends a quiet news week without major corporate headlines, leaving investors to focus on the stock’s recent performance and how it stacks up against global consumer health peers.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:37 CET. Details in the imprint.

Kenvue (US49177J1025) is drawing attention this week mainly through its share performance rather than fresh corporate headlines. With no new filings or major press releases, investors are weighing how the consumer health specialist’s stock has behaved against a stable but competitive peer group.

What the recent week shows

Kenvue stock trades on the New York Stock Exchange under the ticker KVUE after its spin-off from Johnson & Johnson, which was completed in 2023 through an exchange offer and subsequent separation of the consumer health division.

Since that listing, the shares have generally traded in a moderate range as investors digest Kenvue’s standalone financial profile, with a focus on cash generation from well-known over-the-counter brands and how that supports dividends and deleveraging.

How Kenvue compares with peers

In the global consumer health space, Kenvue competes with companies such as Haleon in the UK and Sanofi’s consumer healthcare unit, both of which also rely on portfolios of over-the-counter medicines and personal care products.

Compared with diversified pharma or conglomerate peers, these pure-play consumer health groups are typically viewed as lower-growth but more cash-generative, which can support relatively stable dividend policies and steady balance-sheet management.

How the company makes money

Kenvue generates revenue primarily from consumer health brands across self-care, skin health and beauty and essential health, including labels such as Tylenol, Listerine, Neutrogena and Johnson’s Baby in key markets worldwide.

Where the stock trades today

The shares of Kenvue (US49177J1025) trade on the New York Stock Exchange at $18.17 as of 06/18/2026, 15:59 ET.

Key facts on Kenvue stock

• Company: Kenvue Inc.
• ISIN: US49177J1025
• WKN: A3EEHV
• Ticker: KVUE
• Venue: NYSE
• Price (as of 06/18/2026, 15:59 ET): 18.17 USD
• Market cap: 34,300,000,000 USD (as of 06/18/2026)
• Sector / Industry: Consumer Staples / Consumer Health
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.